CIK 942257
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2023-Q2. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 73.26% | 50 |
| Unclassified | 16.66% | 11 |
| Life Sciences Tools & Services | 9.31% | 2 |
| Health Care Equipment & Supplies | 0.40% | 1 |
| Health Care Providers & Services | 0.36% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | AMGN | AMGEN INC | Health Care | 7.17% |
| 2 | INCY | INCYTE CORP | Health Care | 6.97% |
| 3 | GILD | GILEAD SCIENCES, INC. | Health Care | 5.90% |
| 4 | INTRA-CELLULAR THERAPIES INC | Unclassified | 5.57% | |
| 5 | BMRN | BIOMARIN PHARMACEUTICAL INC | Health Care | 4.58% |
| 6 | SUPN | SUPERNUS PHARMACEUTICALS, INC. | Health Care | 3.96% |
| 7 | VERA | Vera Therapeutics, Inc. | Health Care | 3.50% |
| 8 | BIIB | BIOGEN INC. | Health Care | 3.48% |
| 9 | HRMY | Harmony Biosciences Holdings, Inc. | Health Care | 3.47% |
| 10 | MIRATI THERAPEUTICS INC | Unclassified | 3.17% |
54/65 names classified · sector 83.3% of weight · industry 83.3% · mkt cap 80.8%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 83.3% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 50.4% of book weight (17/56 names) · unclassified 49.6%: , SUPN, VERA, RARE, QURE, AMLX, KRYS, AXSM, ERAS, SRPT +29 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | AMGNAMGEN INC | 79,246 | $21M | 7.2% | TRIM −32% |
| 2 | INCYINCYTE CORP | 358,454 | $21M | 7.0% | HOLD |
| 3 | GILDGILEAD SCIENCES INC | 233,584 | $18M | 5.9% | ADD 62% |
| 4 | INTRA-CELLULAR THERAPIES INC | 317,856 | $17M | 5.6% | ADD 80% |
| 5 | BMRNBIOMARIN PHARMACEUTICAL INC | 153,656 | $14M | 4.6% | ADD 162% |
| 6 | SUPNSUPERNUS PHARMACEUTICALS INC | 426,500 | $12M | 4.0% | TRIM −19% |
| 7 | VERAVERA THERAPEUTICS INC | 758,355 | $10M | 3.5% | TRIM −22% |
| 8 | BIIBBIOGEN INC | 40,200 | $10M | 3.5% | ADD 265% |
| 9 | HRMYHARMONY BIOSCIENCES HLDGS IN | 314,500 | $10M | 3.5% | TRIM −45% |
| 10 | MIRATI THERAPEUTICS INC | 216,000 | $9M | 3.2% | TRIM −17% |
| 11 | RAREULTRAGENYX PHARMACEUTICAL IN | 250,052 | $9M | 3.0% | ADD 212% |
| 12 | QUREUNIQURE NV | 1,241,500 | $8M | 2.8% | ADD 7910% |
| 13 | AUPHAURINIA PHARMACEUTICALS INC | 1,040,530 | $8M | 2.7% | ADD 81% |
| 14 | UTHRUnited Therapeutics Corp. | 33,959 | $8M | 2.6% | TRIM −36% |
| 15 | VRTXVERTEX PHARMACEUTICALS INC | 21,000 | $7M | 2.5% | HOLD |
| 16 | REGNREGENERON PHARMACEUTICALS | 8,847 | $7M | 2.5% | TRIM −67% |
| 17 | ILMNILLUMINA INC | 50,500 | $7M | 2.3% | HOLD |
| 18 | ALNYALNYLAM PHARMACEUTICALS INC | 36,800 | $7M | 2.2% | TRIM −55% |
| 19 | AMLXAMYLYX PHARMACEUTICALS INC | 295,000 | $5M | 1.8% | ADD 1080% |
| 20 | KRYSKRYSTAL BIOTECH INC | 46,092 | $5M | 1.8% | HOLD |
| 21 | KARUNA THERAPEUTICS INC | 30,500 | $5M | 1.7% | ADD 19% |
| 22 | AXSMAXSOME THERAPEUTICS INC. | 58,300 | $4M | 1.4% | HOLD |
| 23 | ERASERASCA INC | 1,926,000 | $4M | 1.3% | ADD 35% |
| 24 | ACADACADIA PHARM | 179,702 | $4M | 1.3% | ADD 19% |
| 25 | REVANCE THERAPEUTICS INC | 288,726 | $3M | 1.1% | HOLD |
| 26 | NBIXNEUROCRINE BIOSCIENCES INC | 28,877 | $3M | 1.1% | TRIM −58% |
| 27 | SRPTSAREPTA THERAPEUTICS INC | 26,700 | $3M | 1.1% | ADD 42% |
| 28 | RCKTROCKET PHARMACEUTICALS INC | 156,000 | $3M | 1.1% | HOLD |
| 29 | DNLIDENALI THERAPEUTICS INC | 154,000 | $3M | 1.1% | TRIM −18% |
| 30 | AZNASTRAZENECA PLC | 46,500 | $3M | 1.1% | NEW |
| 31 | XENEXENON PHARMACEUTICALS INC | 91,500 | $3M | 1.1% | ADD 259% |
| 32 | CRSPCRISPR THERAPEUTICS AG | 63,000 | $3M | 1.0% | NEW |
| 33 | MDGLMADRIGAL PHARMACEUTICALS INC | 18,300 | $3M | 0.9% | HOLD |
| 34 | LEGNLEGEND BIOTECH CORP | 38,000 | $3M | 0.9% | HOLD |
| 35 | HALOHALOZYME THERAPEUTICS INC | 62,200 | $2M | 0.8% | TRIM −35% |
| 36 | MARINUS PHARMACEUTICALS INC | 290,000 | $2M | 0.8% | ADD 222% |
| 37 | ONCBEONE MEDICINES LTD | 12,700 | $2M | 0.8% | ADD 46% |
| 38 | JAZZJAZZ PHARMACEUTICALS PLC | 17,200 | $2M | 0.7% | HOLD |
| 39 | MIRMMIRUM PHARMACEUTICALS INC | 67,500 | $2M | 0.7% | HOLD |
| 40 | IOVAIOVANCE BIOTHERAPEUTICS INC | 445,000 | $2M | 0.7% | ADD 585% |
| 41 | IONSIONIS PHARMACEUTICALS INC | 43,000 | $2M | 0.7% | HOLD |
| 42 | ZLABZAI LAB LTD | 78,958 | $2M | 0.6% | HOLD |
| 43 | GMABGENMAB A/S | 44,300 | $2M | 0.5% | NEW |
| 44 | CLDXCELLDEX THERAPEUTICS INC NEW | 48,099 | $1M | 0.4% | HOLD |
| 45 | COGTCOGENT BIOSCIENCES INC | 135,000 | $1M | 0.4% | NEW |
| 46 | DYNDYNE THERAPEUTICS INC | 137,751 | $1M | 0.4% | TRIM −54% |
| 47 | NVCRNOVOCURE LTD | 74,000 | $1M | 0.4% | ADD 131% |
| 48 | AMICUS THERAPEUTICS INC | 90,000 | $1M | 0.4% | NEW |
| 49 | CYTKCYTOKINETICS INC | 37,000 | $1M | 0.4% | HOLD |
| 50 | GHGUARDANT HEALTH INC | 36,500 | $1M | 0.4% | HOLD |
| 51 | INSMINSMED INC | 40,100 | $1M | 0.3% | HOLD |
| 52 | BLUEPRINT MEDICINES CORP | 20,000 | $1M | 0.3% | NEW |
| 53 | AKERO THERAPEUTICS INC | 18,489 | $935,174 | 0.3% | TRIM −76% |
| 54 | KEZAR LIFE SCIENCES INC | 703,825 | $830,514 | 0.3% | NEW |
| 55 | NTLAINTELLIA THERAPEUTICS INC | 24,000 | $757,920 | 0.3% | HOLD |
| 56 | PRTAPROTHENA CORP PLC | 15,000 | $722,850 | 0.2% | NEW |
| 57 | AGIOAGIOS PHARMACEUTICALS INC | 24,000 | $593,520 | 0.2% | HOLD |
| 58 | BEAMBEAM THERAPEUTICS INC | 23,500 | $564,705 | 0.2% | HOLD |
| 59 | VENTYX BIOSCIENCES INC | 15,000 | $520,650 | 0.2% | HOLD |
| 60 | VIRVIR BIOTECHNOLOGY INC | 47,000 | $439,920 | 0.1% | NEW |
| 61 | NBPNOVABRIDGE BIOSCIENCES | 310,499 | $409,859 | 0.1% | HOLD |
| 62 | PTCTPTC THERAPEUTICS INC | 17,000 | $380,630 | 0.1% | HOLD |
| 63 | ARVNARVINAS INC | 17,000 | $333,540 | 0.1% | HOLD |
| 64 | PTGXPROTAGONIST THERAPEUTICS INC | 19,900 | $331,932 | 0.1% | HOLD |
| 65 | RLMDRELMADA THERAPEUTICS INC | 10,000 | $30,000 | 0.0% | HOLD |
Where this firm's principals came from and which firms its alumni went on to found.
